Japan Ready To Offer Flu Drug For Ebola Treatment
Japan said Monday it is ready to provide a Japanese-developed anti-influenza drug as a possible treatment for the rapidly expanding Ebola outbreak. Chief Cabinet Secretary Yoshihide Suga told reporters that Japan can offer favipiravir, developed by a subsidiary of Fujifilm Holdings Corp., at any time at the request of the World Health Organization. The drug, with the brand name Avigan, was developed by Fujifilm subsidiary Toyama Chemical Co.
“Japan Ready To Offer Flu Drug For Ebola Treatment” is categorized as “world”. This video was licensed from Grab Networks. For additional video content, click the “video” tab at the top of this page.